- Home
- CBUS vs BCIC Comparison
CBUS vs BCIC Comparison
Compare CBUS & BCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBUS | BCIC |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | 13 |
| Industry | Agricultural Chemicals | Finance: Consumer Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5M | 86.9M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | CBUS | BCIC |
|---|---|---|
| Price | $1.93 | $7.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | $9.00 | $9.00 |
| AVG Volume (30 Days) | ★ 458.8K | 41.4K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 14.14% |
| EPS Growth | ★ 74.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,639,000.00 | N/A |
| Revenue This Year | $112.72 | $0.00 |
| Revenue Next Year | $83.18 | N/A |
| P/E Ratio | ★ N/A | $7.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $6.70 |
| 52 Week High | $4.19 | $13.50 |
Technical Indicators
Market Signals| Indicator | CBUS | BCIC |
|---|---|---|
| Relative Strength Index (RSI) | 58.72 | 44.94 |
| Support Level | $1.51 | $6.70 |
| Resistance Level | $2.49 | $7.63 |
| Average True Range (ATR) | 0.22 | 0.16 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 35.75 | 39.53 |
Price Performance
Historical ComparisonAbout CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About BCIC BCP Investment Corporation
BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.